EGF and TGF-β1 effects on thyroid function

Journal of Thyroid Research

Volumn 2011, Issue , 2011, Pages

  Mincione, Gabriella ^a   Di Marcantonio, Maria Carmela ^a   Tarantelli, Chiara ^a   D'Inzeo, Sonia ^b   Nicolussi, Arianna ^b   Nardi, Francesco ^b   Donini, Caterina Francesca ^b   Coppa, Anna ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SODIUM IODIDE SYMPORTER; THYROID TRANSCRIPTION FACTOR 1; THYROTROPIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADVANCED CANCER; CARCINOGENESIS; CELL CULTURE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; DIFFERENTIATION; ENZYME ACTIVATION; ENZYME INHIBITION; EPITHELIUM CELL; GENE AMPLIFICATION; GENE CONTROL; GENE MUTATION; GENE OVEREXPRESSION; GROWTH INHIBITION; MALIGNANT TRANSFORMATION; METASTASIS; MOLECULAR INTERACTION; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; THYROID CANCER; THYROID CELL; THYROID FUNCTION; THYROID TUMOR; TUMOR PROMOTION; TUMOR SUPPRESSOR GENE;

EID: 84876574158     PISSN: 20908067     EISSN: 20420072     Source Type: Journal    
DOI: 10.4061/2011/431718     Document Type: Review

References (135)

1. G. Vassart and J. E. Dumont, "The thyrotropin receptor and the regulation of thyrocyte function and growth", Endocrine Reviews, vol. 13, no. 3, pp. 596-611, 1992.
2. D. M. Kingsley, "The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms", Genes and Development, vol. 8, no. 2, pp. 133-146, 1994.
3. S. E. Wang, A. Narasanna, M. Perez-Torres et al., "HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors", Cancer Cell, vol. 10, no. 1, pp. 25-38, 2006.
4. G. Colletta, A. M. Cirafici, and A. Di Carlo, "Dual effect of transforming growth factor beta on rat thyroid cells: inhibition of thyrotropin-induced proliferation and reduction of thyroid-specific differentiation markers", Cancer Research, vol. 49, no. 13, pp. 3457-3462, 1989. (Pubitemid 19178158)
5. L. M. Asmis, H. Gerber, J. Kaempf, and H. Studer, "Epidermal growth factor stimulates cell proliferation and inhibits iodide uptake of FRTL-5 cells in vitro", Journal of Endocrinology, vol. 145, no. 3, pp. 513-520, 1995.
6. J. Massaguè, S. W. Blain, and R. S. Lo, "TGFbeta signaling in growth control, cancer, and heritable disorders", Cell, vol. 103, no. 2, pp. 295-309, 2000.
7. J. E. Dumont, C. Maenhaut, and F. Lamy, "Control of thyroid cell proliferation and goitrogenesis", Trends in Endocrinology and Metabolism, vol. 3, no. 1, pp. 12-17, 1992.
8. A. M. Musti, V. M. Ursini, E. V. Avvedimento, V. Zimarino, and R. D. Lauro, "A cell type specific factor recognizes the rat thyroglobulin promoter", Nucleic Acids Research, vol. 15, no. 20, pp. 8149-8166, 1987.
9. M. Zannini, V. Avantaggiato, E. Biffali et al., "TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation", EMBO Journal, vol. 16, no. 11, pp. 3185-3197, 1997. (Pubitemid 27234957)
10. M. Zannini, H. Francis-Lang, D. Plachov, and R. Di Lauro, "Pax-8, a paired domain-containing protein, binds to a sequence overlapping the recognition site of a homeodomain and activates transcription from two thyroid-specific promoters", Molecular and Cellular Biology, vol. 12, no. 9, pp. 4230-4241, 1992.
11. P. P. Roger, M. Taton, J. Van Sande, and J. E. Dumont, "Mitogenic effects of thyrotropin and adenosine 3', 5'-monophosphate in differentiated normal human thyroid cells in vitro", Journal of Clinical Endocrinology and Metabolism, vol. 66, no. 6, pp. 1158-1165, 1988.
12. S. Filetti and B. Rapoport, "Autoregulation by iodine of thyroid protein synthesis: influence of iodine on amino acid transport in cultured thyroid cells", Endocrinology, vol. 114, no. 4, pp. 1379-1385, 1984. (Pubitemid 14134393)
13. B. Van Heuverswyn, A. Leriche, J. Van Sande, J. E. Dumont, and G. Vassart, "Transcriptional control of thyroglobulin gene expression by cyclic AMP", FEBS Letters, vol. 188, no. 2, pp. 192-196, 1985. (Pubitemid 16249732)
14. D. Tramontano, G. W. Cushing, A. C. Moses, and S. H. Ingbar, "Insulin-like growth factor-I stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves'-IgG", Endocrinology, vol. 119, no. 2, pp. 940-942, 1986. (Pubitemid 16048857)
15. P. Santisteban, L. D. Kohn, and R. Di Lauro, "Thyroglobulin gene expression is regulated by insulin and insulin-like growth factor I, as well as thyrotropin, in FRTL-5 thyroid cells", Journal of Biological Chemistry, vol. 262, no. 9, pp. 4048-4052, 1987.
16. M. Saji, T. Akamizu, M. Sanchez et al., "Regulation of thyrotropin receptor gene expression in rat FRTL-5 thyroid cells", Endocrinology, vol. 130, no. 1, pp. 520-533, 1992.
17. Y. Yarden and M. X. Sliwkowski, "Untangling the ErbB signalling network", Nature Reviews Molecular Cell Biology, vol. 2, no. 2, pp. 127-137, 2001. (Pubitemid 33674041)
18. R. Pinkas-Kramarski, L. Soussan, H. Waterman et al., " Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions", EMBO Journal, vol. 15, no. 10, pp. 2452-2467, 1996. (Pubitemid 26151185)
19. D. Graus-Porta, R. R. Beerli, J. M. Daly, and N. E. Hynes, "ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling", EMBO Journal, vol. 16, no. 7, pp. 1647-1655, 1997. (Pubitemid 27151960)
20. M. Alimandi, A. Romano, M. C. Curia et al., "Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas", Oncogene, vol. 10, no. 9, pp. 1813-1821, 1995.
21. S. V. Sharma, D. W. Bell, J. Settleman, and D. A. Haber, "Epidermal growth factor receptor mutations in lung cancer", Nature Reviews Cancer, vol. 7, no. 3, pp. 169-181, 2007.
22. D. S. Salomon, R. Brandt, F. Ciardiello, and N. Normanno, "Epidermal growth factor-related peptides and their receptors in human malignancies", Critical Reviews in Oncology/Hematology, vol. 19, no. 3, pp. 183-232, 1995.
23. R. Zandi, A. B. Larsen, P. Andersen, M.-T. Stockhausen, and H. S. Poulsen, "Mechanisms for oncogenic activation of the epidermal growth factor receptor", Cellular Signalling, vol. 19, no. 10, pp. 2013-2023, 2007. (Pubitemid 47353811)
24. D. K. Moscatello, M. Holgado-Madruga, A. K. Godwin et al., "Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors", Cancer Research, vol. 55, no. 23, pp. 5536-5539, 1995.
25. D. J. Slamon, G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich, and W. L. McGuire, "Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene", Science, vol. 235, no. 4785, pp. 177-182, 1987. (Pubitemid 17231334)
26. J. W. Lee, Y. H. Soung, S. H. Seo et al., "Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas", Clinical Cancer Research, vol. 12, no. 1, pp. 57-61, 2006. (Pubitemid 43166176)
27. P. Stephens, C. Hunter, G. Bignell et al., "Lung cancer: intragenic ERBB2 kinase mutations in tumours", Nature, vol. 431, no. 7008, pp. 525-526, 2004.
28. H. Shigematsu, T. Takahashi, M. Nomura et al., "Somatic mutations of the HER2 kinase domain in lung adenocarcinomas", Cancer Research, vol. 65, no. 5, pp. 1642-1646, 2005. (Pubitemid 40478587)
29. R. Naidu, M. Yadav, S. Nair, and M. K. Kutty, "Expression of c-erbB3 protein in primary breast carcinomas", British Journal of Cancer, vol. 78, no. 10, pp. 1385-1390, 1998. (Pubitemid 28495255)
30. C. A. Maurer, H. Friess, B. Kretschmann et al., "Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2", Human Pathology, vol. 29, no. 8, pp. 771-777, 1998. (Pubitemid 28375981)
31. M. Kobayashi, A. Iwamatsu, A. Shinohara-Kanda, S. Ihara, and Y. Fukui, "Activation of ErbB3-PI3-kinase pathway is correlated with malignant phenotypes of adenocarcinomas", Oncogene, vol. 22, no. 9, pp. 1294-1301, 2003. (Pubitemid 36384590)
32. T. Rajkumar, G. W. H. Stamp, C. M. Hughes, and W. J. Gullick, "c-erbB3 protein expression in ovarian cancer", Journal of Clinical Pathology, vol. 49, no. 4, pp. M199-M202, 1996. (Pubitemid 26259644)
33. H. Friess, L. Wang, Z. Zhu et al., "Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas", Annals of Surgery, vol. 230, no. 6, pp. 767-775, 1999. (Pubitemid 30191811)
34. T. Holbro, R. R. Beerli, F. Maurer, M. Koziczak, C. F. Barbas III, and N. E. Hynes, "The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation", Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 15, pp. 8933-8938, 2003. (Pubitemid 36899201)
35. T. T. Junttila, M. Sundvall, J. A. Määttä, and K. Elenius, "ErbB4 and its isoforms: selective regulation of growth factor responses by naturally occurring receptor variants", Trends in Cardiovascular Medicine, vol. 10, no. 7, pp. 304-310, 2000. (Pubitemid 32422109)
36. J. A. Määttä, M. Sundvall, T. T. Junttila et al., "Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth", Molecular Biology of the Cell, vol. 17, no. 1, pp. 67-79, 2006. (Pubitemid 43049462)
37. C. C. Lynch, T. Vargo-Gogola, M. D. Martin, B. Fingleton, H. C. Crawford, and L. M. Matrisian, "Matrix metalloproteinase 7 mediates mammary epithelial cell tumorigenesis through the ErbB4 receptor", Cancer Research, vol. 67, no. 14, pp. 6760-6767, 2007. (Pubitemid 47105523)
38. R. S. Muraoka-Cook, L. S. Caskey, M. A. Sandahl et al., "Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1", Molecular and Cellular Biology, vol. 26, no. 17, pp. 6412-6424, 2006. (Pubitemid 44277882)
39. T. Hoelting, A. E. Siperstein, O. H. Clark, and Q.-Y. Duh, "Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo", Journal of Clinical Endocrinology and Metabolism, vol. 79, no. 2, pp. 401-408, 1994. (Pubitemid 24256526)
40. B. F. Van der Laan, J. L. Freeman, and S. L. Asa, "Expression of growth factors and growth factor receptors in normal and tumorous human thyroid tissues", Thyroid, vol. 5, no. 1, pp. 67-73, 1995.
41. G. Bechtner, D. Schopohl, M. Rafferzeder, R. Gärtner, and U. Welsch, "Stimulation of thyroid cell proliferation by epidermal growth factor is different from cell growth induced by thyrotropin or insulin-like growth factor I", European Journal of Endocrinology, vol. 134, no. 5, pp. 639-648, 1996. (Pubitemid 26188536)
42. B. Gabler, T. Aicher, P. Heiss, and R. Senekowitsch-Schmidtke, "Growth inhibition of human papillary thyroid carcinoma cells and multicellular spheroids by anti-EGF-receptor antibody", Anticancer Research, vol. 17, no. 4, pp. 3157-3159, 1997. (Pubitemid 27434881)
43. Y. Mizukami, A. Nonomura, T. Hashimoto et al., "Immunohistochemical demonstration of epidermal growth factor and c-myc oncogene product in normal, benign and malignant thyroid tissues", Histopathology, vol. 18, no. 1, pp. 11-18, 1991.
44. V. Gorgoulis, D. Aninos, C. Priftis et al., "Expression of epidermal growth factor, transforming growth factor-alpha and epidermal growth factor receptor in thyroid tumors", In Vivo, vol. 6, no. 3, pp. 291-296, 1992.
45. R. Aasland, J. R. Lillehaug, R. Male, O. Josendal, J. E. Varhaug, and K. Kleppe, "Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB", British Journal of Cancer, vol. 57, no. 4, pp. 358-363, 1988.
46. D. R. Haugen, L. A. Akslen, J. E. Verhaug, and J. R. Lillehaug, "Demonstration of a TGF-alpha-EGF-receptor autocrine loop and c-myc protein over-expression in papillary thyroid carcinomas", International Journal of Cancer, vol. 55, no. 1, pp. 37-43, 1993. (Pubitemid 23261703)
47. G. Mincione, A. Piccirelli, D. Lazzereschi, D. S. Salomon, and G. Colletta, "Heregulin-dependent autocrine loop regulates growth of K-ras but not erbB-2 transformed rat thyroid epithelial cells", Journal of Cellular Physiology, vol. 176, no. 2, pp. 383-391, 1998. (Pubitemid 28319722)
48. O. Fluge, L. A. Akslen, D. R. F. Haugen, J. E. Varhaug, and J. R. Lillehaug, "Expression of heregulins and associations with the ErbB family of tyrosine kinase receptors in papillary thyroid carcinomas", International Journal of Cancer, vol. 87, no. 6, pp. 763-770, 2000. (Pubitemid 30660552)
49. J. D. Bergstrom, B. Westermark, and N.-E. Heldin, "Epidermal growth factor receptor signaling activates met in human anaplastic thyroid carcinoma cells", Experimental Cell Research, vol. 259, no. 1, pp. 293-299, 2000.
50. B. Song, "Immunohistochemical demonstration of epidermal growth factor receptor and ceruloplasmin in thyroid diseases", Acta Pathologica Japonica, vol. 41, no. 5, pp. 336-343, 1991.
51. B. A. Schiff, A. B. McMurphy, S. A. Jasser et al., "Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer", Clinical Cancer Research, vol. 10, no. 24, pp. 8594-8602, 2004. (Pubitemid 40053427)
52. S. Hoffmann, S. Gläser, A. Wunderlich et al., "Targeting the EGF/VEGF-R system by tyrosine-kinase inhibitors-a novel antiproliferative/ antiangiogenic strategy in thyroid cancer", Langenbeck's Archives of Surgery, vol. 391, no. 6, pp. 589-596, 2006. (Pubitemid 44657740)
53. L. A. Akslen, A. O. Myking, H. Salvesen, and J. E. Varhaug, "Prognostic impact of EGF-receptor in papillary thyroid carcinoma", British Journal of Cancer, vol. 68, no. 4, pp. 808-812, 1993. (Pubitemid 23301291)
54. U. Marti, C. Ruchti, J. Kämpf et al., "Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues", Thyroid, vol. 11, no. 2, pp. 137-145, 2001. (Pubitemid 32221036)
55. J. C. Utrilla, I. Martin-Lacave, M. V. San Martin, J. M. Fernandex-Santos, and H. Galera-Davidson, "Expression of c-erbB-2 oncoprotein in human thyroid tumours", Histopathology, vol. 34, no. 1, pp. 60-65, 1999. (Pubitemid 29049078)
56. D. R. F. Haugen, L. A. Akslen, J. E. Varhaug, and J. R. Lillehaug, "Expression of c-erbB-2 protein in papillary thyroid carcinomas", British Journal of Cancer, vol. 65, no. 6, pp. 832-837, 1992.
57. T. Murakawa, H. Tsuda, T. Tanimoto, T. Tanabe, S. Kitahara, and O. Matsubara, "Expression of KIT, EGFR, HER-2 and tyrosine phosphorylation in undifferentiated thyroid carcinoma: implication for a new therapeutic approach", Pathology International, vol. 55, no. 12, pp. 757-765, 2005. (Pubitemid 43110201)
58. S. L. Sugg, S. Ezzat, L. Zheng, I. B. Rosen, J. L. Freeman, and S. L. Asa, "Cytoplasmic staining of erbB-2 but not mRNA levels correlates with differentiation in human thyroid neoplasia", Clinical Endocrinology, vol. 49, no. 5, pp. 629-637, 1998. (Pubitemid 28529762)
59. D. Gumurdulu, A. Uguz, S. Erdogan, I. Tuncer, and O. Demircan, "Expression of c-erbB-2 oncoprotein in different types of thyroid tumors: an immunohistochemical study", Endocrine Research, vol. 29, no. 4, pp. 465-472, 2003. (Pubitemid 37517847)
60. L. A. Akslen and J. E. Varhaug, "Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival", Cancer, vol. 76, no. 9, pp. 1643-1654, 1995.
61. R. Kremser, P. Obrist, G. Spizzo et al., "Her2/neu overexpression in differentiated thyroid carcinomas predicts metastatic disease", Virchows Archiv, vol. 442, no. 4, pp. 322-328, 2003. (Pubitemid 36561088)
62. S. M. Wiseman, O. L. Griffith, A. Melck et al., "Evaluation of type 1 growth factor receptor family expression in benign and malignant thyroid lesions", The American Journal of Surgery, vol. 195, no. 5, pp. 667-673, 2008. (Pubitemid 351540818)
63. S. Kato, T. Kobayashi, K. Yamada et al., "Expression of erbB receptors mRNA in thyroid tissues", Biochimica et Biophysica Acta, vol. 1673, no. 3, pp. 194-200, 2004. (Pubitemid 38981773)
64. D. R. F. Haugen, L. A. Akslen, J. E. Varhaug, and J. R. Lillehaug, "Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas", Cancer Research, vol. 56, no. 6, pp. 1184-1188, 1996. (Pubitemid 26080951)
65. A. Logan, C. Smith, G. P. Becks, A. M. Gonzalez, I. D. Phillips, and D. J. Hill, "Enhanced expression of transforming growth factor-β1 during thyroid hyperplasia in rats", Journal of Endocrinology, vol. 141, no. 1, pp. 45-57, 1994. (Pubitemid 24141976)
66. A. Coppa, G. Mincione, S. Mammarella, A. Ranieri, and G. Colletta, "Epithelial rat thyroid cell clones, escaping from transforming growth factor beta negative growth control, are still inhibited by this factor in the ability to trap iodide", Cell Growth and Differentiation, vol. 6, no. 3, pp. 281-290, 1995.
67. L. Attisano and J. L. Wrana, "Smads as transcriptional comodulators", Current Opinion in Cell Biology, vol. 12, no. 2, pp. 235-243, 2000.
68. T. Imamura, M. Takase, A. Nishihara et al., "Smad6 inhibits signalling by the TGF-beta superfamily", Nature, vol. 389, no. 6651, pp. 622-626, 1997. (Pubitemid 27446182)
69. A. Nakao, M. Afrakhte, A. Morén et al., "Identification of Smad7, a TGFbeta-inducible antagonist of TGFbeta signalling", Nature, vol. 389, no. 6651, pp. 631-635, 1997. (Pubitemid 27446184)
70. C. Suzuki, G. Murakami, M. Fukuchi et al., "Smurf1 regulates the inhibitory activity of Smad7 by targeting Smad7 to the plasma membrane", Journal of Biological Chemistry, vol. 277, no. 42, pp. 39919-39925, 2002. (Pubitemid 35190978)
71. B. Grubeck-Loebenstein, G. Buchan, R. Sadeghi et al., "Transforming growth factor beta regulates thyroid growth. Role in the pathogenesis of nontoxic goiter", Journal of Clinical Investigation, vol. 83, no. 3, pp. 764-770, 1989. (Pubitemid 19080603)
72. F. Depoortere, I. Pirson, J. Bartek, J. E. Dumont, and P. P. Roger, "Transforming growth factor beta (1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1)", Molecular Biology of the Cell, vol. 11, no. 3, pp. 1061-1076, 2000. (Pubitemid 30159322)
73. A. Franzén, E. Piek, B. Westermark, P. Ten Dijke, and N.-E. Heldin, "Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function", Endocrinology, vol. 140, no. 9, pp. 4300-4310, 1999. (Pubitemid 30647129)
74. C. Carneiro, C. V. Alvarez, J. Zalvide, A. Vidal, and F. Doḿinguez, "TGF-beta1 actions on FRTL-5 cells provide a model for the physiological regulation of thyroid growth", Oncogene, vol. 16, no. 11, pp. 1455-1465, 1998. (Pubitemid 28151852)
75. X.-P. Pang, M. Park, and J. M. Hershman, "Transforming growth factor-beta blocks protein kinase-A-mediated iodide transport and protein kinase-C-mediated DNA synthesis in FRTL-5 rat thyroid cells", Endocrinology, vol. 131, no. 1, pp. 45-50, 1992.
76. A. Kawaguchi, M. Ikeda, T. Endo, T. Kogai, A. Miyazaki, and T. Onaya, "Transforming growth factor-beta1 suppresses thyrotropin-induced Na+/I-symporter messenger RNA and protein levels in FRTL-5 rat thyroid cells", Thyroid, vol. 7, no. 5, pp. 789-794, 1997. (Pubitemid 28086214)
77. A. E. Pekary and J. M. Hershman, "Tumor necrosis factor, ceramide, transforming growth factor-beta1, and aging reduce Na+/I-symporter messenger ribonucleic acid levels in FRTL-5 cells", Endocrinology, vol. 139, no. 2, pp. 703-712, 1998. (Pubitemid 28513222)
78. A. E. Pekary, S. R. Levin, D. G. Johnson, L. Berg, and J. M. Hershman, "Tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor-beta 1 (TGF-beta 1) inhibit the expression and activity of Na +/K (+)-ATPase in FRTL-5 rat thyroid cells", Journal of Interferon and Cytokine Research, vol. 17, no. 4, pp. 185-195, 1997. (Pubitemid 27368598)
79. M. Taton, F. Lamy, P. P. Roger, and J. E. Dumont, "General inhibition by transforming growth factor beta 1 of thyrotropin and cAMP responses in human thyroid cells in primary culture", Molecular and Cellular Endocrinology, vol. 95, no. 1-2, pp. 13-21, 1993. (Pubitemid 23267191)
80. D. Claisse, I. Martiny, B. Chaqour et al., "Influence of transforming growth factor beta1 (TGF-beta1) on the behaviour of porcine thyroid epithelial cells in primary culture through thrombospondin-1 synthesis", Molecular and Cellular Endocrinology, vol. 112, part 9, pp. 1405-1416, 1999. (Pubitemid 29243463)
81. H.-C. Kang, M. Ohmori, N. Harii, T. Endo, and T. Onaya, "Pax-8 is essential for regulation of the thyroglobulin gene by transforming growth factor-beta1", Endocrinology, vol. 142, no. 1, pp. 267-275, 2001. (Pubitemid 32183688)
82. A. Nicolussi, S. D'Inzeo, M. Santulli, G. Colletta, and A. Coppa, "TGF-beta control of rat thyroid follicular cells differentiation", Molecular and Cellular Endocrinology, vol. 207, no. 1-2, pp. 1-11, 2003. (Pubitemid 37102948)
83. E. Costamagna, B. Garćia, and P. Santisteban, "The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-beta repression of the sodium/iodide symporter gene", Journal of Biological Chemistry, vol. 279, no. 5, pp. 3439-3446, 2004. (Pubitemid 38140582)
84. N. Delorme, C. Remond, H. Sartelet et al., "TGFbeta1 effects on functional activity of porcine thyroid cells cultured in suspension", Journal of Endocrinology, vol. 173, no. 2, pp. 345-355, 2002. (Pubitemid 34552463)
85. G. Kotlarz, Y. Wegrowski, L. Martiny, P. J. Declerck, and G. Bellon, "Enhanced expression of plasminogen activator inhibitor-1 by dedifferentiated thyrocytes", Biochemical and Biophysical Research Communications, vol. 295, no. 3, pp. 737-743, 2002. (Pubitemid 34756911)
86. Y. Wegrowski, C. Perreau, L. Martiny, B. Haye, F. X. Maquart, and G. Bellon, "Transforming growth factor beta-1 up-regulates clusterin synthesis in thyroid epithelial cells", Experimental Cell Research, vol. 247, no. 2, pp. 475-483, 1999. (Pubitemid 29394785)
87. C. Garbi, G. Colletta, A. M. Cirafici, P. C. Marchisio, and L. Nitsch, "Transforming growth factor-beta induces cytoskeleton and extracellular matrix modifications in FRTL-5 thyroid epithelial cells", European Journal of Cell Biology, vol. 53, no. 2, pp. 281-289, 1990.
88. G. Napolitano, V. Montani, C. Giuliani et al., "Transforming growth factor-beta1 down-regulation of major histocompatibility complex class I in thyrocytes: coordinate regulation of two separate elements by thyroid-specific as well as ubiquitous transcription factors", Molecular Endocrinology, vol. 14, no. 4, pp. 486-505, 2000. (Pubitemid 32260519)
89. M. Matsumura, N. Banba, S. Motohashi, and Y. Hattori, "Interleukin-6 and transforming growth factor-beta regulate the expression of monocyte chemoattractant protein-1 and colony-stimulating factors in human thyroid follicular cells", Life Sciences, vol. 65, no. 12, pp. PL129-PL135, 1999. (Pubitemid 29425969)
90. Y.-C. L. Tseng, S. Lahiri, S. Jackson, K. D. Burman, and L. Wartofsky, "Endothelin binding to receptors and endothelin production by human thyroid follicular cells: effects of transforming growth factor-beta and thyrotropin", Journal of Clinical Endocrinology and Metabolism, vol. 76, no. 1, pp. 156-161, 1993. (Pubitemid 23027571)
91. M. J. Truty and R. Urrutia, "Basics of TGF-beta and pancreatic cancer", Pancreatology, vol. 7, no. 5-6, pp. 423-435, 2007.
92. J. Massagué, "TGFβ in cancer", Cell, vol. 134, no. 2, pp. 215-230, 2008.
93. L. Davies and H. G. Welch, "Increasing incidence of thyroid cancer in the United States, 1973-2002", Journal of the American Medical Association, vol. 295, no. 18, pp. 2164-2167, 2006.
94. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M. J. Thun, "Cancer statistics, 2007", CA: A Cancer Journal for Clinicians, vol. 57, no. 1, pp. 43-66, 2007. (Pubitemid 46148091)
95. V. Vasko, A. V. Espinosa, W. Scouten et al., "Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion", Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 8, pp. 2803-2808, 2007. (Pubitemid 46327960)
96. S. P. Bidey, D. J. Hill, and M. C. Eggo, "Growth factors and goitrogenesis", Journal of Endocrinology, vol. 160, no. 3, pp. 321-332, 1999. (Pubitemid 29182824)
97. M. A. Pisarev, L. Thomasz, and G. J. Juvenal, "Role of transforming growth factor beta in the regulation of thyroid function and growth", Thyroid, vol. 19, no. 8, pp. 881-892, 2009.
98. D. Vesely, J. Astl, P. Lastuvka, P. Matucha, I. Sterzl, and J. Betka, "Serum levels of IGF-I, HGF, TGFbeta1, bFGF and VEGF in thyroid gland tumors", Physiological Research, vol. 53, no. 1, pp. 83-89, 2004. (Pubitemid 38295545)
99. L. Levy and C. S. Hill, "Alterations in components of the TGF-beta superfamily signaling pathways in human cancer", Cytokine and Growth Factor Reviews, vol. 17, no. 1-2, pp. 41-58, 2006. (Pubitemid 43117515)
100. D. Lazzereschi, A. Ranieri, G. Mincione, S. Taccogna, F. Nardi, and G. Colletta, "Human malignant thyroid tumors displayed reduced levels of transforming growth factor beta receptor type II messenger RNA and protein", Cancer Research, vol. 57, no. 10, pp. 2071-2076, 1997. (Pubitemid 27209743)
101. Y. Imamura, L. Jin, J. P. Grande et al., "Analysis of TGF-β and TGF-β-RII in thyroid neoplasms from the United States, Japan, and China", Endocrine Pathology, vol. 9, no. 3, pp. 209-216, 1998. (Pubitemid 28536796)
102. J. Seoane, "Escaping from the TGFbeta anti-proliferative control", Carcinogenesis, vol. 27, no. 11, pp. 2148-2156, 2006.
103. J. West, T. Munoz-Antonia, J. G. Johnson, D. Klotch, and C. A. Muro-Cacho, "Transforming growth factor-beta type II receptor and Smad proteins in follicular thyroid tumors", Laryngoscope, vol. 110, no. 8, pp. 1323-1327, 2000. (Pubitemid 30626100)
104. A. Turco, A. Coppa, S. Aloe et al., "Overexpression of transforming growth factor beta-type II receptor reduces tumorigenicity and metastastic potential of K-ras-transformed thyroid cells", International Journal of Cancer, vol. 80, no. 1, pp. 85-91, 1999. (Pubitemid 28559782)
105. A. Nicolussi, S. D'Inzeo, A. Gismondi, and A. Coppa, "Reduction of invasive potential in K-ras-transformed thyroid cells by restoring of TGF-β pathway", Clinical and Experimental Metastasis, vol. 23, no. 5-6, pp. 237-248, 2006.
106. T. Hölting, A. Zielke, A. E. Siperstein, O. H. Clark, and Q.-Y. Duh, "Transforming growth factor-beta 1 is a negative regulator for differentiated thyroid cancer: studies of growth, migration, invasion, and adhesion of cultured follicular and papillary thyroid cancer cell lines", Journal of Clinical Endocrinology and Metabolism, vol. 79, no. 3, pp. 806-813, 1994.
107. S. E. Matsuo, S. G. Leoni, A. Colquhoun, and E. T. Kimura, "Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells", Journal of Endocrinology, vol. 190, no. 1, pp. 141-150, 2006. (Pubitemid 44161069)
108. N. E. Heldin, D. Bergström, A. Hermansson et al., "Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells", Molecular and Cellular Endocrinology, vol. 153, no. 1-2, pp. 79-90, 1999. (Pubitemid 29339159)
109. D. Lazzereschi, F. Nardi, A. Turco et al., "A complex pattern of mutations and abnormal splicing of Smad4 is present in thyroid tumours", Oncogene, vol. 24, no. 34, pp. 5344-5354, 2005. (Pubitemid 43080104)
110. S. D'Inzeo, A. Nicolussi, A. Ricci et al., "Role of reduced expression of SMAD4 in papillary thyroid carcinoma", Journal of Molecular Endocrinology, vol. 45, no. 4, pp. 229-244, 2010.
111. A. Moustakas and C. H. Heldin, "The regulation of TGFbeta signal transduction", Development, vol. 136, no. 22, pp. 3699-3714, 2009.
112. J. M. Cerutti, K. N. Ebina, S. E. Matsuo, L. Martins, R. M. B. Maciel, and E. T. Kimura, "Expression of Smad4 and Smad7 in human thyroid follicular carcinoma cell lines", Journal of Endocrinological Investigation, vol. 26, no. 6, pp. 516-521, 2003. (Pubitemid 36998699)
113. S. E. Matsuo, A. P. Z. Fiore, S. M. Siguematu et al., "Expression of SMAD proteins, TGF-beta/activin signaling mediators, in human thyroid tissues", Arquivos Brasileiros de Endocrinologia & Metabologia, vol. 54, no. 4, pp. 406-412, 2010.
114. D. Padua and J. Massagué, "Roles of TGFbeta in metastasis.", Cell Research, vol. 19, no. 1, pp. 89-102, 2009.
115. G. Riesco-Eizaguirre, I. Rodŕiguez, A. De La Vieja et al., "The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer", Cancer Research, vol. 69, no. 21, pp. 8317-8325, 2009.
116. R. Visone, P. Pallante, A. Vecchione et al., "Specific microRNAs are downregulated in human thyroid anaplastic carcinomas", Oncogene, vol. 26, no. 54, pp. 7590-7595, 2007. (Pubitemid 350207711)
117. J. Braun, C. Hoang-Vu, H. Dralle, and S. Hüttelmaier, "Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas", Oncogene, vol. 29, no. 29, pp. 4237-4244, 2010.
118. M. Ariga, T. Nedachi, M. Akahori et al., "Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells", Biochemical Journal, vol. 348, part 2, pp. 409-416, 2000. (Pubitemid 30345215)
119. G. Mincione, D. L. Esposito, M. C. Di Marcantonio, A. Piccirelli, A. Cama, and G. Colletta, "TGF-β1 modulation of IGF-I signaling pathway in rat thyroid epithelial cells", Experimental Cell Research, vol. 287, no. 2, pp. 411-423, 2003. (Pubitemid 37323852)
120. A. B. Roberts and L. M. Wakefield, "The two faces of transforming growth factor β in carcinogenesis", Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 15, pp. 8621-8623, 2003. (Pubitemid 36899145)
121. G. Torre-Amione, R. D. Beauchamp, H. Koeppen et al., "A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance", Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 4, pp. 1486-1490, 1990.
122. M. P. De Caestecker, W. T. Parks, C. J. Frank et al., "Smad2 transduces common signals from receptor serinethreonine and tyrosine kinases", Genes and Development, vol. 12, no. 11, pp. 1587-1592, 1998. (Pubitemid 28299510)
123. M. Kretzschmar, J. Doody, and J. Massagué, "Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1", Nature, vol. 389, no. 6651, pp. 618-622, 1997. (Pubitemid 27446181)
124. M. Kretzschmar, J. Doody, I. Timokhina, and J. Massagué, "A mechanism of repression of TGFfβ/Smad signaling by oncogenic Ras", Genes and Development, vol. 13, no. 7, pp. 804-816, 1999. (Pubitemid 29169840)
125. M. M. Murillo, G. Del Castillo, A. Sánchez, M. Fernández, and I. Fabregat, "Involvement of EGF receptor and c-Src in the survival signals induced by TGF-β1 in hepatocytes", Oncogene, vol. 24, no. 28, pp. 4580-4587, 2005. (Pubitemid 41032621)
126. G. Del Castillo, M. M. Murillo, A. Alvarez-Barrientos et al., "Autocrine production of TGF-β confers resistance to apoptosis after an epithelial-mesenchymal transition process in hepatocytes: role of EGF receptor ligands", Experimental Cell Research, vol. 312, no. 15, pp. 2860-2871, 2006.
127. K. Song, T. L. Krebs, and D. Danielpour, "Novel permissive role of epidermal growth factor in transforming growth factor β (TGF-β) signaling and growth suppression. Mediation by stabilization of TGF-β receptor type II", Journal of Biological Chemistry, vol. 281, no. 12, pp. 7765-7774, 2006. (Pubitemid 43847390)
128. S. Uttamsingh, X. Bao, and K. T. Nguyen, "Synergistic effect between EGF and TGF-β1 in inducing oncogenic properties of intestinal epithelial cells", Oncogene, vol. 27, no. 18, pp. 2626-2634, 2008. (Pubitemid 351550880)
129. P. M. Siegel, W. Shu, R. D. Cardiff, W. J. Muller, and J. Massagué, "Transforming growth factor β signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis", Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8430-8435, 2003. (Pubitemid 36842562)
130. S. E. Seton-Rogers and J. S. Brugge, "ErbB2 and TGF-beta: a cooperative role in mammary tumor progression?" Cell Cycle, vol. 3, no. 5, pp. 597-600, 2004. (Pubitemid 40278199)
131. M. Andrianifahanana, M. C. Wilkes, C. E. Repellin et al., "ERBB receptor activation is required for profibrotic responses to transforming growth factor β", Cancer Research, vol. 70, no. 19, pp. 7421-7430, 2010.
132. G. Mincione, M. Cirafici, D. Lazzereschi, S. Pepe, F. Ciardiello, and G. Colletta, "Loss of thyrotropin regulation and transforming growth factor beta-induced growth arrest in erbB-2 overexpressing rat thyroid cells", Cancer Research, vol. 53, no. 22, pp. 5548-5553, 1993. (Pubitemid 23342182)
133. M. Nilsson, T. Dahlman, B. Westermark, and K. Westermark, "Transforming growth factor-β promotes epidermal growth factor-induced thyroid cell migration and follicle neoformation in collagen gel separable from cell proliferation", Experimental Cell Research, vol. 220, no. 2, pp. 257-265, 1995.
134. H. Mishima, M. Nakamura, J. Murakami, T. Nishida, and T. Otori, "Transforming growth factor-beta modulates effects of epidermal growth factor on corneal epithelial cells", Current Eye Research, vol. 11, no. 7, pp. 691-696, 1992.
135. S. Hoffmann, L. C. Hofbauer, V. Scharrenbach et al., "Thyrotropin (TSH)-induced production of vascular endothelial growth factor in thyroid cancer cells in vitro: evaluation of TSH signal transduction and of angiogenesisstimulating growth factors", Journal of Clinical Endocrinology & Metabolism, vol. 89, no. 12, pp. 6139-6145, 2004. (Pubitemid 39628426)